Sodium Iodide (I-131) Solution, Therapeutic Oral, packaged as a) 1 ml V-vial, NDC 69208-003-15; O...

FDA Recall #D-0389-2026 — Class II — January 26, 2026

Recall #D-0389-2026 Date: January 26, 2026 Classification: Class II Status: Ongoing

Product Description

Sodium Iodide (I-131) Solution, Therapeutic Oral, packaged as a) 1 ml V-vial, NDC 69208-003-15; Order 49317, 49323, 49325, 49329, 49333, 49339, 49341,49355, 49364, 49380, 49392. (b) 2 ml V-Vial, NDC 69208-003-25; Order 49353,49457, 49477. (c) 3 ml V-vial, NDC 69208-003-35; Order 49454,49406. Rx Only, Manufactured by: International Isotopes Inc., Idaho Falls, ID.

Reason for Recall

Presence of Particulate Matter: Due to production issues

Recalling Firm

Radnostix — Idaho Falls, ID

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

16 units

Distribution

Nationwide in the USA and Puerto Rico

Code Information

Batch I012626R-01, Exp 02/09/2026

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated